Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FCYHN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,063
Award facts
- Contract value 100% obligated
- $10,062.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,062.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Renflexis 100 mg vials, with an ultimate completion date of July 9, 2025. This non-set-aside competitive award represents a single delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems across multiple therapeutic domains.
Renflexis is a biosimilar to Remicade (infliximab) used in treating various inflammatory conditions including rheumatoid arthritis and Crohn's disease. As a child contract under the DLA Troop Support Medical IDC, this delivery order exemplifies the agency's approach to securing pharmaceutical supplies through established prime vendor relationships. The award reflects the Defense Logistics Agency's pharmaceutical procurement strategy, which relies on competitively awarded indefinite delivery contracts to enable efficient distribution of critical medical commodities to support defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FCYHN?
SPE2DB25FCYHN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 8, 2025.
How much is contract SPE2DB25FCYHN worth?
The government has obligated $10,063 on SPE2DB25FCYHN.
Is contract SPE2DB25FCYHN an order under another contract?
Yes. SPE2DB25FCYHN is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCYHN competed?
The extent of competition for SPE2DB25FCYHN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award